Following a first project on refractory or relapsed cancers after CAR-T treatment (CARREL), a second project was initiated by the team at Saint-Louis Hospital, in order to focus on relapses occurring more than 3 months after CAR-T treatment.
Indeed, relapses following CAR-T occur largely in the first 3 months after treatment. This research aims to better understand the profile of the patients who relapse later (age, CAR-T administered…) and the best therapeutic options for them following relapse.
The analyses of this project are done by the LYSARC, using data from patients diagnosed with B-cell lymphoma and included in the registry before end of April 2022.
To the patients that received CAR-T, if you would like more information about the treatment of your data in the DESCAR-T Registry, you can contact the doctor at your centre of care for your CAR-T treatment or make a request at dpo@lysarc.org. You can find more details your rights regarding your data in the section “I am participating or have participated in a clinical trial“, or in the Patient Information Leaflet you received at the time of your inclusion in the registry.